From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians

“Sermo Physician Community Launches – Marks New Era for Bedside Observation,” Businesswire.com, September 26, 2006, available at <http://www.businesswire.com/news/home/20060926005403/en/Sermo-Physician-Community-Launches—Marks-Era> (last visited June 19, 2013).

“Replacing the Hospital Water Cooler,” Medicine on the Net, March 2007, 1–3, at 3, available at <http://www.hcpro.com/content/67540.pdf> (last viewed June 19, 2013).

On Sermo, physicians are required to provide personal information only when they register on the site, so that the company can confirm they are licensed to practice medicine in the United States. See “Discuss + Connect,” Sermo.com, available at <http://www.sermo.com/take-a-tour/discuss-connect> (last viewed June 19, 2013).

“Earn Honoria,” Sermo.com, available at <http://www.sermo.com/take-a-tour/earn-honoraria> (last viewed June 19, 2013).

Sermo homepage, available at <http://www.sermo.com/> (last viewed June 19, 2013).

Bureau of Labor Statistics, U.S. Department of Labor, Occupational Outlook Handbook, 2012–2013 Edition, Physicians and Surgeons, available at <http://www.bls.gov/ooh/healthcare/physicians-and-surgeons.htm> (last viewed June 19, 2013).

Reece R. L. , “A Conversation with the Founder of Sermo,” Health Leaders Media, October 18, 2007, available at <http://www.healthleadersmedia.com/content/PHY-200363/A-Conversation-With-the-Founder-of-Sermo.html> (last viewed June 18, 2013).

See “Replacing the Hospital Water Cooler,” supra note 2.

“Sermo Closes $3 Million in Series A Round Funding from Longworth Venture Partners,” Businesswire.com, September 26, 2006, available at <http://www.businesswire.com/news/home/20060926005393/en/Sermo-Closes-3-Million-Series-Funding-Longworth> (last viewed June 18, 2013).

Calnan C. , “Sermo Socks Away $27M in Third Funding Round,” Boston Business Journal, September 11, 2007, available at <http://www.bizjournals.com/boston/blog/mass-hightech/2007/09/sermo-socks-away-27m-in-third-funding-round.html/> (last visited April 8, 2013).

Id.

“Sermo Partners with Penn Center for Bioethics to Develop Ethical Guidelines for Market-Based Clinical Informatics,” Businesswire.com, October 27, 2006, available at <http://www.businesswire.com/news/home/20061027005361/en/Sermo-Partners-Penn-Center-Bioethics-Develop-Ethical> (last visited June 18, 2013).

Robeznieks A. , “Ethicist Inks Deal with For-Profit,” Modern Healthcare 36, no. 45 (November 13, 2006): 8–9.

Vox F. , “When Doctors Talk …,” Newsweek, March 9, 2009, available at <http://www.thedailybeast.com/newsweek/2009/03/09/when-doctors-talk.html> (last viewed June 18, 2013).

Id.

The FDA went against the advisory panel's recommendation and asked Dendreon to provide more evidence of safety and efficacy before granting approval of Provenge in April 2010.

Halperin A. , “The Wisdom of the Medical Crowd,” Businessweek, April 29, 2007, available at <http://www.businessweek.com/stories/2007-04-29/the-wisdom-of-the-medical-crowd-businessweek-business-news-stock-market-and-financial-advice> (last viewed June 18, 2013).

Id.

Id.

Chase J. , “Sermo, Bloomberg Partner on Service for Healthcare Investors,” Medical Marketing & Media, October 23, 2008, available at <http://www.mmm-online.com/sermo-bloomberg-partner-on-service-for-healthcare-investors/article/119831/> (last viewed June 18, 2013).

Johnson A. , “Pfizer-Doctors Web Pact May Get Looks,” Wall Street Journal, October 15, 2007, at 84.

Hensley S. , “Pfizer Follows Docs Online with Sermo,” Wall Street Journal, October 15, 2007, available at <http://blogs.wsj.com/health/2007/10/15/pfizer-follows-docs-online-with-sermo/> (last viewed June 19, 2013).

Bordoloi P. Gazo A. Paranjpe K. Clausen M. Fierro L. , “Medical Information Services: The Age of Social Media and New Customer Channels,” Drug Information Journal 45, no. 6 (2011): 811–818, at 812.

Id., at 812.

Sanofi Aventis, Sanofi-Aventis U.S., U.S. Educational Grant Transparency Report, 1st Quarter 2009, available at <https://www.sagrants.com/docs/Grant_Transparency_report_qtr01_09.pdf> (last viewed June 18, 2013).

University of Pennsylvania, “‘The New Business of Medicine’ Series,” available at <http://www.cesearchengine.com/ce_details.php?ce_id=5654> (last viewed April 8, 2013).

Arnold M. , “Pharmas, Wall Streeters Lurk on ‘MySpace for Docs,’” Medical Marketing & Media, May 2007, at 8.

Id.

See, Sismondo S. , “Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light On,” Journal of Law, Medicine & Ethics 41, no. 3 (2013): 635–643.

Cutting Edge Information, “Pharmaceutical Thought Leaders: Brand Strategies and Product Positioning,” Report PH64 (2004).

Coleman J. S. Katz E. Manzel H. , Medical Innovation: A Diffusion Study (New York: Bobbs-Merrill Co., 1966).

“Sermo Business Solutions Capabilities,” available through <http://www.sermo.com/solutions> (last viewed June 18, 2013).

Arnold M. , “Sermo Revamp Aims for Faster Searchers, Better Filters, Alerts,” Medical Marketing & Media, July 14, 2010, available at <http://www.mmm-online.com/sermo-revampaims-for-faster-searches-better-filters-alerts/article/174608/> (last viewed June 19, 2013).

See, Rodwin M. , “Five Un-Easy Pieces to Pharmaceutical Policy Reform,” Journal of Law, Medicine & Ethics 41, no. 3 (2013): 581–589.

Parmar A. , “Sermo vs. Doximity: Can They Coexist in Fight to Build Physician-Only Networks?” MedCity News, March 21, 2012, available at <http://medcitynews.com/2012/03/sermo-vs-doximity-can-they-co-exist-in-fight-to-build-physician-only-networks/> (last viewed June 19, 2013).

Id.

Tangney Jeff , interview by Williams David E. , Health Business Blog (March 8, 2012), at <http://www.healthbusinessblog.com/2012/03/doximity-professional-network-for-physicians-transcript/> (last viewed June 19, 2013).

Id.

Wilson D. , “Drug App Comes Free, Ads Included,” New York Times, July 29, 2011, at B1.

See in this issue of the Journal of Law, Medicine & Ethics 41, no. 3 (2013): Sah S. Fugh-Berman A. , “Physicians under the Influence: Social Psychology and Industry Marketing Strategies,” at 665–672, and Light D. W. Lexchin J. Darrow J. , “Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs,” at 590–600.